In 2024, the U.S. Drug Enforcement Administration (DEA) indicated which they plan to reclassify marijuana as a Schedule III drug. This rescheduling will realize that cannabis has legitimate healthcare functions and will help open up the door to research on other opportunity procedure takes advan